Pegloticase is PEG-recombinant uricase [EC:1.7.3.3]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M04 ANTIGOUT PREPARATIONS
M04A ANTIGOUT PREPARATIONS
M04AX Other antigout preparations
M04AX02 Pegloticase
D09316 Pegloticase (USAN/INN) <US>
USP drug classification [BR:br08302]
Antigout Agents
Pegloticase
D09316 Pegloticase (USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09316
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09316
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D09316
